Please try another search
Bio Vitos Pharma AB (publ) operates as a medical technology company in Sweden and internationally. The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples. It serves emergency departments in the European Union and the United States. It has a collaboration agreement with KFUM Kalmar to conduct a research study. The company was formerly known as Hemcheck Sweden AB (publ) and changed its name to Bio Vitos Pharma AB (publ) in December 2023. Bio Vitos Pharma AB (publ) was incorporated in 2010 and is based in Solna, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Måns Alfvén | 50 | 2015 | Deputy Director |
Mathias Karlsson | 52 | 2022 | Director |
Salvatore Di Somma | - | - | Member of Clinical Advisory Board |
Richard Wall | - | 2023 | President of the Board |
Anna Klevby Dalgaard | 45 | 2018 | Director |
Karin Dahllof | 65 | 2018 | Independent Director |
Michael Christ | - | - | Member of Clinical Advisory Board |
Jorge Ordonez-Llanos | - | - | Member of Clinical Advisory Board |
Olle Melander | - | - | Member of Clinical Advisory Board |
Igor Locot | - | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review